Evidence map›Paper›PMID 38880369›Full record

ArticleCryobiology2024

Polyethylene glycol and caspase inhibitor emricasan alleviate cold injury in primary rat hepatocytes.

Huyun Chen, Bradley W Ellis, Antonia T Dinicu, Mohammadreza Mojoudi, Benjamin T Wilks, Shannon N Tessier, Mehmet Toner, Korkut Uygun, Basak E Uygun

Abstract read
In one paragraph

Article in Cryobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Huyun ChenCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Bradley W EllisCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Antonia T DinicuCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Mohammadreza MojoudiCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Benjamin T WilksCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Shannon N TessierCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Mehmet TonerCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Korkut UygunCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA.
Basak E UygunCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Shriners Children's Boston, Boston, MA, USA. Electronic address: basakuygun@mgh.harvard.edu.

Funding

High subzero preservation of liver for transplantationR01DK114506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET, UYGUN, KORKUT · 2017 to 2025
$4.4M
Metabolic Modeling for Cadaveric Organ ResuscitationR01DK096075 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT, YEH, HEIDI · 2012 to 2022
$3.9M
Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservationR01EB028782 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Biju Parekkadan, Korkut Uygun · 2021 to 2026
$3.1M
High subzero heart preservation: from zebrafish to mammalsR01HL157803 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Shannon Noella Tessier · 2021 to 2026
$2.8M
Cryopreservation of zebrafish larvae and embryos for biomedical researchR24OD034189 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI Shannon Noella Tessier · 2023 to 2026
$2.6M
A quantitative viability metric for liver transplantation using Resonance Raman SpectroscopyR01DK134590 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Shannon Noella Tessier · 2023 to 2026
$1.9M
Development of engineered fasciocutaneous skin flapsR01AR082825 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Basak Elif Uygun · 2023 to 2026
$1.4M
Development of Capillary-on-Chip for the Study of Preservation Injury on Microvascular Endothelial CellsF32HL176334 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Bradley Wayne Ellis · 2024 to 2026
$242k
NHLBI NIH HHS F32 HL176334NHLBI NIH HHS R01 HL157803NIAMS NIH HHS R01 AR082825NIBIB NIH HHS R01 EB028782NIDDK NIH HHS R01 DK096075NIDDK NIH HHS R01 DK114506NIDDK NIH HHS R01 DK134590NIH HHS R24 OD034189
6 · The paper itself

Abstract

Current methods of storing explanted donor livers at 4 °C in University of Wisconsin (UW) solution result in loss of graft function and ultimately lead to less-than-ideal outcomes post transplantation. Our lab has previously shown that supplementing UW solution with 35-kilodalton polyethylene glycol (PEG) has membrane stabilizing effects for cold stored primary rat hepatocytes in suspension. Expanding on past studies, we here investigate if PEG has the same beneficial effects in an adherent primary rat hepatocyte cold storage model. In addition, we investigated the extent of cold-induced apoptosis through treating cold-stored hepatocytes with pan caspase inhibitor emricasan. In parallel to storage at the current cold storage standard of 4 °C, we investigated the effects of lowering the storage temperature to -4 °C, at which the storage solution remains ice-free due to the supercooling phenomenon. We show the addition of 5 % PEG to the storage medium significantly reduced the release of lactate dehydrogenase (LDH) in plated rat hepatocytes and a combinatorial treatment with emricasan maintains hepatocyte viability and morphology following recovery from cold storage. These results show that cold-stored hepatocytes undergo multiple mechanisms of cold-induced injury and that PEG and emricasan treatment in combination with supercooling may improve cell and organ preservation.

Indexed as

ApoptosisCaspase InhibitorsCryopreservationHepatocytesL-Lactate DehydrogenaseOrgan Preservation SolutionsPolyethylene GlycolsAdenosineAllopurinolAnimalsCells, CulturedCell SurvivalCold TemperatureCryoprotective AgentsGlutathioneInsulin3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acidAdenosineAllopurinolCaspase InhibitorsCryoprotective AgentsGlutathioneInsulinL-Lactate DehydrogenaseOrgan Preservation SolutionsPentanoic AcidsPolyethylene GlycolsRaffinoseUniversity of Wisconsin-lactobionate solution

Identifiers

PMID38880369
PMCPMC11374468

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.